India goes after Roche for ripping rivals
The Competition Commission of India has greenlighted its investigative branch to probe Swiss drugmaker Hoffmann La-Roche for allegedly trying to sabotage Mylan Pharmaceuticals and another company from entering a cancer drug market.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.